Vanguard Group Inc Biolife Solutions Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,897,270 shares of BLFS stock, worth $73.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,897,270
Previous 2,804,140
3.32%
Holding current value
$73.9 Million
Previous $64 Million
2.56%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.4MCall Options Held
0Put Options Held
0-
Casdin Capital, LLC New York, NY7.71MShares$197 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$140 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$108 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$91.3 Million0.01% of portfolio
-
State Street Corp Boston, MA1.41MShares$35.9 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.09B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...